Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, P.P.Box 12000, Israel
NCT Number: NCT04431128
500 children aged 0-5 years followed since birth by Principal Investigator (PI)since January1, 2003 till December 31, 2018 and diagnosed with adenoid hypertrophy (AH) (study group) and 500 children aged 0-5 years followed by principal investigator during the same years and diagnosed as urinary tract infection (UTI), gastroenteritis (GE), diarrhea, vomiting but without AH (control group) were compared. Morbidity and treatment will be compared and correlated with gastro-esophageal reflux (GER), allergy and infant feeding position during the first few years of life in the two groups.
Looking for future studies?
Notify Me1 month–5 year
All sexes
Observational
Jerusalem, P.P.Box 12000, Israel
The 2 groups are children aged 0-5 years and treated by PI and followed since birth during years 2003-2018. Study group consists of children diagnosed at least 2 times as AH and control group as similar children with UTI, GE, vomiting or diarrhea. Respiratory problems (pneumonia, bronchopneumonia, bronchitis), ear problems (otitis media OM, serous OM), antibiotic treatment, use of bronchodilators, inhaled corticosteroid (ICS), chest X-rays, anomalous laboratory results, emergency room visits and hospitalization rates will be compared in the two groups, together with details concerning feeding position during the first years of life. Correlation between morbidity, degree of nasopharyngeal obstruction, allergy, GER and supine feeding position, will be evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Study group: Young children with diagnosis of adenoid hypertrophy followed by PI Control group: young children with diagnosis of UTI, GE, vomiting or diarrhea followed by PI
Exclusion criteria
Children with cystic fibrosis, primary dyskinesia, immune deficiency, congenital anatomical malformations of nasal or airway passages.
Children older than 6 months of age when starting to be followed by PI.
correlation with allergy, GER or feeding position
Time frame: 3 years
Number of participants with Pneumonia, bronchitis
Time frame: 3 years
Number of participants with otitis media, serous otitis media
Time frame: 5 years
Correlation between respiratory morbidity, ear morbidity, laboratory and chest & nasopharynx X-rays with feeding position in first year of life
Correlation between respiratory and ENT morbidity with degree of adenoid obstruction, allergy, GER and infant feeding position during the first 2 years of life.
Hadassah Medical Organization
Other
Adenoid Hypertrophy, Etiology, Clinical Manifestations and Related Morbidity, Correlation With Infant Feeding Position
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06841432
Adenoid Hypertrophy, Adenoidectomy
Asyut, Egypt
View Trial DetailsNCT03902314
Adenoid Hypertrophy, Children, Only
Providence, Rhode Island, United States
View Trial DetailsNCT03714919
Adenoid Hypertrophy
Columbus, Ohio, United States
View Trial DetailsNCT03677453
Adenoid Hypertrophy, Congenital Abnormalities
Columbus, Ohio, United States
View Trial Details